Abstract

Lipid nanoemulsions are attractive drug delivery systems for lipophilic drugs. To produce nanoemulsions with droplets of very small diameter (<100 nm), we investigated thermotropic phase transitions as an alternative to the standard procedure of high-pressure homogenization. Employing shock dilution with ice-cold water during the phase inversion gives the opportunity to produce nanoemulsions without any use of potentially toxic organic solvents. The systematic investigation of the relation of the three involved components surfactant, aqueous phase and lipid phase showed that depending on the ratio of surfactant to lipid the emulsions contained particles of diameters between 16 and 175 nm with narrow polydispersity index distributions and uncharged surfaces. Nanoemulsions with particles of 50 and 100 nm in diameter showed very little toxicity to fibroblast cells in vitro. An unusual, exponential-like nonlinear increase in osmolality was observed with increasing concentration of the nonionic surfactant Kolliphor HS 15. The experimental results indicate, that nanoemulsions with particles of small and tunable size can be easily formed without homogenization by thermal cycling.

Highlights

  • Nanoscaled drug delivery systems such as solid lipid or polymeric nanoparticles, nanocapsules, liquid nanoemulsions, liposomes and micelles can be used to carry poorly water soluble ingredients of pharmaceuticals for parenteral applications [1,2,3]

  • The salinity did not have a significant influence on the particle diameter and the polydispersity index (PDI) of the nanoemulsion formed by shock dilution

  • The solutions corresponding to the grey zones did not yield any stable nanoemulsions because they (1) resulted in creaming and/or coalescence directly after the shock dilution, or (2) the phase inversion temperature was higher than the boiling point of the aqueous phase

Read more

Summary

Introduction

Nanoscaled drug delivery systems such as solid lipid or polymeric nanoparticles, nanocapsules, liquid nanoemulsions, liposomes and micelles can be used to carry poorly water soluble ingredients of pharmaceuticals for parenteral applications [1,2,3]. Thereby, the physical entrapment of the active ingredients into the core of the nanoparticles gives the possibility to solubilize and protect the sensitive drugs or contrast agents [2,4,5] Their pharmacokinetics, including the distribution from the blood stream into the tissue, depend mainly on the size and shape, the surface composition, the charge as well as the flexibility of the Beilstein J. The choice and the amount of the surfactant show different effects on the final product These factors influence the feasibility of forming stable nanostructures, they affect the phase inversion zone, the in vitro cellular toxicity and the above mentioned particle and surface properties [3,4,12]

Objectives
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call